Case Report: Development of RA in Transplanted Hands

Share this content:
Case Report: Development of RA in Transplanted Hands
Case Report: Development of RA in Transplanted Hands

WEDNESDAY, June 28, 2017 (HealthDay News) -- In a case report published online June 27 in the Annals of Internal Medicine, rheumatoid arthritis is diagnosed in the hands of a patient who underwent bilateral hand transplantation.

Brittany L. Adler, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues present the case of rheumatoid arthritis in a woman who received allogeneic bilateral hand and forearm transplants at age 33 years. No personal or family history of rheumatoid arthritis was reported for the donor or recipient.

The authors note that the patient developed subacute bilateral hand pain and swelling one year after transplantation, but the patient's elbows, shoulders, and knees were not affected. The graft continued to function normally. Blood test results were negative for rheumatoid factor, anti-cyclic citrullinated peptide antibodies, and antinuclear antigen, while the level of C-reactive protein was elevated to 6.5 mg/dL. Palpable bilateral synovitis in the metacarpophalangeal, proximal interphalangeal, and wrist joints was confirmed in ultrasonography and magnetic resonance imaging, with evidence of synovitis and effusions, moderate tenosynovitis, and erosive changes. Methotrexate and prednisone were added to the maintenance tacrolimus therapy. Three years later, the patient developed new swan-neck deformities with radiographic erosions, despite ongoing immunosuppression.

"To our knowledge, this is the first report of rheumatoid arthritis in a hand transplant recipient," the authors write. "Whether it constitutes an atypical transplant rejection is unclear."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths